In a study of prostate cancer xenografts, Sakai et al found that increased Bcl-2 expression enhanced the expression and secretion of key lymphangiogenic factors and increased serum IL-8 contents, which correlated with increased angiogenic and lymphangiogenic levels in vivo (35). The gene discussed is BCL2; the disease is Familial prostate cancer.